ESTIMATING MORBIDITY COSTS ATTRIBUTABLE TO BREAST CANCER AMONG YOUNGER WOMEN AGED 18 TO 44 YEARS—UNITED STATES, 2000–2010

Author(s)

Ekwueme DU1, Trogdon J2, Khavjou O3, Guy Jr. G1, Li C1
1Centers for Disease Control and Prevention, Atlanta, GA, USA, 2University of North Carolina at Chapel Hill, Chapel Hill, GA, USA, 3RTI International, Chapel Hill, NC, USA

OBJECTIVES: Although breast cancer occurs primarily among women over age 50 years, each year more than 10,000 cases are diagnosed among women aged 18-44 years.  To date, no study has specifically quantified the economic burden of breast cancer in this age group in the United States.  This study is the first to estimate work and home productivity losses due to breast cancer among younger women aged 18-44 years. METHODS: We used a two-part regression model and data from the 2000–2010 National Health Interview Survey to estimate the number of work and home productivity days missed due to breast cancer, adjusted for socioeconomic characteristics and comorbidities. We compared our estimates for younger women with those of older women aged 45-64 years. RESULTS: Per capita, younger women with breast cancer had annual losses of $2,293 (95% confidence interval [CI]: $1,069-$3,518) from missed work and $288 (95% CI: $105-$471) from missed home productivity. Younger women too sick to work had annual breast cancer-attributable work loss costs of $365 per person (95% CI: $208-$522). In total, breast cancer-attributable morbidity costs for younger women were $274 million (95% CI: $128-$420 million) for work loss among the employed, $46 million (95% CI: $17-$75 million) for home productivity, and $10 million (95% CI: $6-$15 million) for work loss among women too sick to work.  Older women with breast cancer had lower per capita work loss costs but higher total morbidity costs. CONCLUSIONS: Younger women with breast cancer face significant work and home productivity losses. These results underscore the importance of continued efforts by the public health community to support the unique needs of younger breast cancer survivors and promote prevention efforts throughout the lifespan.

Conference/Value in Health Info

2014-05, ISPOR 2014, Palais des Congres de Montreal

Value in Health, Vol. 17, No. 3 (May 2014)

Code

PHS28

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies, Cost-comparison, Effectiveness, Utility, Benefit Analysis, Work & Home Productivity - Indirect Costs

Disease

Oncology

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×